Aerovate Therapeutics is a startup based in the United States, most recent round Acquired, 2 tracked investors.
Aerovate Therapeutics is a company headquartered in the United States. Aerovate Therapeutics has been acquired. Brouky records 2 investors associated with the company.
Aerovate Therapeutics is a clinical-stage biopharmaceutical company focused on developing inhaled therapies for patients with debilitating pulmonary diseases. Its lead product candidate is an inhaled formulation of an established anti-fibrotic agent for the treatment of idiopathic pulmonary fibrosis.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.